Former Ph.D. students at MMS | ||
Matteo Pavan | 2020-2022 | Tackling the covid-19
pandemic through the combination of established and novel computer-aided drug
discovery workflows. |
Davide Bassani | 2020-2022 | Application, evaluation, and improvement of computational methodologies in drug discovery |
Giovanni Bolcato | 2017-2019 | Combining computational time-independent with time-dependent approaches in Drug discovery. |
Maicol Bissaro | 2017-2019 | From fragment to lead compound: spotting the role of computational approaches |
Enruico Margiotta | 2016-2018 | Molecular modelling of drug-receptor halogen bonds and G protein-coupled receptors ligands design. |
Veronica Salmaso | 2015-2017 | |
Giseppe Deganutti | 2014-2016 | Ligand-receptor binding events decoded at the molecular scale by means of molecular dynamics simulations. |
Alberto Cuzzolin | 2013-2015 | Novel in silico approaches to depict the protein-ligand recognition events. |
Andrea Cristiani | 2012-2015 | Molecular dynamics simulations and in silico mutagenesis: from in vitro to in silico and from clinics to molecular modeling. |
Davide Sabbadin | 2011-2013 | G protein-coupled receptors as a drug traget: investigation receptor topology and ligand recognition harnessing the power of Graphical Processing Units. |
Marco Fanton | 2010-2012 | Chemoinformatic approchaes for new drugs discovery. |
Silvia Paoletta | 2009-2011 | Designing adenosine receptors antagonists using an in silico approach. |
Serena Basili | 2006-2008 | Computational approaches for the rational design of novel Topoisomerase I poisons as potential anticancer drugs. |
Erika Morizzo | 2006-2008 | G protein-coupled receptors as potential drug target: from receptor topology to rational drug design: an in silico approach. |
Andrea Bortolato | 2005-2007 | Rational design of new protein kinases inhibitors of pharmaceutical interest. |
Loris Moretti | 2004-2006 | Exploring structure and plasticity of tyrosine kinase domains for drug discovery. |
Magdalena Bacilieri | 2003-2005 | 3D-QSARs as powerful drug design tool: from concept to application. |
Silvia Bosio | 2002-2004 | Progettazione, sintesi e caratterizzazione di nuovi inibitori della protein chinasi CK2. |
Ileana Menegazzo | 2001-2004 | Spettroscopia di risonanza magnetica nucleare in chimica farmaceutica: applicazioni, limiti e prospettive. |
Diego Dal Ben | 2002-2004 | Human Topoisomerase II as anticancer drug target: new insight into its molecular function using a combined molecular modeling approach. |
Francesca Deflorian | 2002-2004 | Studio computazionale sulle modalità di binding di antagonisti competitivi della glicina nei recettori NMDA. |
Alessandro Brigo | 2001-2003 | Comparative computational studies on HIV-1 integrase: a novel approach to target-based drug design. |